Keyphrases
NF-B
100%
Human B Cells
100%
β-cell Proliferation
100%
Osteoprotegerin
100%
Denosumab
100%
Ligand Pathways
100%
Human Cells
42%
Aged Mice
42%
Cell Proliferation
42%
Cell Replication
42%
Rodents
28%
Diabetes
28%
Receptor Activator of nuclear factor-κB Ligand (RANKL)
28%
Adult Humans
28%
Cell Mass
28%
Diabetic Mice
28%
Osteoporosis Drugs
28%
Pancreatic Cells
14%
Glycogen Synthase Kinase 3 (GSK3)
14%
Repurposing
14%
Dedifferentiation
14%
Hyperglycemia
14%
Specific Antibodies
14%
Humanized Mice
14%
Proliferation in Vitro
14%
Mitogen
14%
FDA-approved Drugs
14%
Lactogen
14%
Braking
14%
Decoy Receptor
14%
Binding Receptors
14%
Medicine and Dentistry
Cell Proliferation
100%
Receptor
100%
Beta Cell
100%
Osteoprotegerin
100%
Denosumab
100%
Osteoclast Differentiation Factor
57%
Cell Division
42%
Diabetes
28%
Diabetes Mellitus
28%
Osteoporosis
28%
Rodent Cell
28%
Receptor Binding
14%
In Vitro
14%
Hyperglycemia
14%
Antibodies
14%
Prolactin
14%
Cell Dedifferentiation
14%
Mitogenic Agent
14%
Immunology and Microbiology
Cell Proliferation
100%
Osteoprotegerin
100%
Denosumab
100%
RANKL
57%
Human Cell
42%
Cell Division
42%
Receptor Binding
14%
Humanized Mouse
14%
Mitogen
14%
RANK
14%
Cell Dedifferentiation
14%
Antibodies
14%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Osteoprotegerin
100%
Denosumab
100%
Osteoclast Differentiation Factor
57%
Diabetes Mellitus
28%
Repurposing
14%
Antibodies
14%
Hyperglycemia
14%
Prolactin
14%
Mitogenic Agent
14%